Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 26 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

42%

11 trials in Phase 3/4

Results Transparency

0%

0 of 16 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 1
11(42.3%)
Phase 3
10(38.5%)
Phase 2
3(11.5%)
N/A
1(3.8%)
Phase 4
1(3.8%)
26Total
Phase 1(11)
Phase 3(10)
Phase 2(3)
N/A(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (26)

Showing 20 of 26 trials
NCT06388070Phase 3Completed

To Evaluate the Efficacy and Safety of HUC3-053 in Patients With Dry Eye Syndrome

Role: lead

NCT07337174Phase 1Not Yet Recruiting

Study to Compare and Evaluate the Safety and Pharmacokinetics After Subcutaneous Injection of HUC2-676 or HUC2-676-R in Healthy Adult Subjects

Role: lead

NCT07335211Phase 3Recruiting

Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Role: lead

NCT06263998Phase 1Recruiting

Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops

Role: lead

NCT06618079Phase 1Active Not Recruiting

Drug-Drug Interaction Study Between HUC2-565-A and HUC2-565-B

Role: lead

NCT05743764Phase 3Completed

HU007 in Patients with Dry Eye Syndrome

Role: lead

NCT06552182Phase 1Completed

Phase 1 Study in Diabetes Mellitus(Fasting)

Role: lead

NCT06551740Phase 1Completed

Phase 1 Study in Diabetes Mellitus(Fed)

Role: lead

NCT05289921Phase 3Completed

To Evaluate HU-014 in the Treatment of Post Stroke Upper Limb

Role: lead

NCT05298449Phase 2Completed

Phase 2 of HU-045 in Glabellar Lines

Role: lead

NCT04415346Phase 1Unknown

A Single Center, Phase I Clinical Trial to Evaluate the Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity

Role: lead

NCT04384991Phase 3Completed

HU007 Eye Drops in Patients With Dry Eye Syndrome

Role: lead

NCT03461575Phase 3Completed

Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome

Role: lead

NCT04224649Not ApplicableUnknown

To Evaluate the Efficacy and Safety of Injection With HARA as Compared to Restylane® Lidocaine in Temporary Correction of Nasolabial Folds

Role: lead

NCT04081402Phase 3Unknown

A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox® in Subjects With Moderate to Severe Crow's Feet Lines

Role: lead

NCT02917512Phase 2Completed

Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome

Role: lead

NCT03440671Phase 3Unknown

The Safety and Efficacy Study of Hutox Versus Botox® in Subject With Moderate to Severe Glabellar Lines

Role: lead

NCT03495739Phase 1Unknown

Clinical Trial to Assess the Safety and Pharmacokinetics of RDG-17012 Capsule and Pradaxa® Capsule in Healthy Male Volunteers

Role: lead

NCT02893098Phase 3Completed

A Study to Evaluate the Safety and Efficacy of Humia Inj. in Patients With Symptomatic Osteoarthritis of the Knee

Role: lead

NCT02902523Phase 1Completed

Clinical Trial to Assess the Safety and Pharmacokinetics of HUG116 Tablet and Viread® Tablet in Healthy Male Volunteers

Role: lead